AGA Medical

Plymouth, United States Founded: 1995 • Age: 31 yrs Listed Acquired By St. Jude Medical
Devices to treat congenital heart diseases and peripheral vascular diseases

About AGA Medical

AGA Medical is a Healthcare company based in Plymouth (United States) founded in 1995, and was acquired by St. Jude Medical in October 2010. Devices to treat congenital heart diseases and peripheral vascular diseases. AGA Medical offers products and services including AVEIR DR Leadless Pacemaker, Assurity MRI Pacemaker, Gallant ICD, Assert-IQ ICM, and Merlin.net Patient Care Network. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is AGA Medical Corporation. Its competitors include PECA Labs, Endonovo Therapeutics and Coherex; 2 of its 3 listed competitors have raised funding.

Company details

The Company produces devices to treat congenital heart and peripheral vascular diseases. The companys products are aimed at interventional cardiologists, electro physiologists, vascular surgeons and interventional radiologists. Its structural heart defect products include Amplatzer Septal Occluders for the closure of holes; Amplatzer Duct Occluder intended for closure of patent ductus arteriosus; Amplatzer Ventricular Septal Defect (VSD) Occluders to address Ventricular Septal Defects; Amplatzer patent foramen ovale (PFO) Occluder for the closure of PFOs; and Amplatzer Cardiac Plug for occlusion of the left atrial appendage. The companys devices for vascular disease comprise Amplatzer Vascular Plugs for closure of abnormal blood vessels; and Amplatzer Vascular Grafts for the treatment of iliac artery aneurysms. In 2010, AGA Medical Holdings was acquired by St. Jude Medical for 1.08B.

Key Metrics

Products & Services of AGA Medical

AGA Medical offers a comprehensive portfolio of products and services, including AVEIR DR Leadless Pacemaker, Assurity MRI Pacemaker, Gallant ICD, Assert-IQ ICM, and Merlin.net Patient Care Network.

AVEIR DR Leadless Pacemaker
Pacemaker

Dual chamber system for heart pacing without leads.

Assurity MRI Pacemaker
Pacemaker

Wireless device for MRI-compatible heart rhythm support.

Gallant ICD
Defibrillator

Implantable device for arrhythmia detection and therapy.

Assert-IQ ICM
Monitoring Device

Insertable monitor for long-term cardiac data collection.

Merlin.net Patient Care Network
Remote System

Platform for device monitoring and programming remotely.

Investors in AGA Medical

AGA Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include St. Jude Medical.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Medical devices for cardiac and neuromodulation therapies are manufactured globally.
1976sjm.comSaint Paul, United States
Premium access

Investor details for AGA Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of AGA Medical

3 dated milestones of AGA Medical across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded AGA Medical is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Exit Acquired by St. Jude Medical.

Competitors of AGA Medical

AGA Medical has 3 listed competitors in our database, 2 of them funded. They include PECA Labs, Endonovo Therapeutics and Coherex.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pecalabs.com2011Pittsburgh, United States$19.91M
Pediatric cardiac surgical devices are developed for congenital heart defects.
endonovo.com2011Los Angeles, United States
Bioelectronic devices are developed for regenerative medicine therapies.
coherex.com2003Salt Lake, United States$25.03M19
Structural heart disease conditions are addressed with implant devices.
Premium access

Detailed competitors of AGA Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as AGA Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about AGA Medical

AGA Medical was founded in 1995.

AGA Medical is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.

The Company produces devices to treat congenital heart and peripheral vascular diseases. The companys products are aimed at interventional cardiologists, electro physiologists, vascular surgeons and interventional radiologists. Its structural heart defect products include Amplatzer Septal Occluders for the closure of holes; Amplatzer Duct Occluder intended for closure of patent ductus arteriosus; Amplatzer Ventricular Septal Defect (VSD) Occluders to address Ventricular Septal Defects; Amplatzer patent foramen ovale (PFO) Occluder for the closure of PFOs; and Amplatzer Cardiac Plug for occlusion of the left atrial appendage. The companys devices for vascular disease comprise Amplatzer Vascular Plugs for closure of abnormal blood vessels; and Amplatzer Vascular Grafts for the treatment of iliac artery aneurysms. In 2010, AGA Medical Holdings was acquired by St. Jude Medical for 1.08B.

AGA Medical's top competitors include PECA Labs, Endonovo Therapeutics and Coherex.

AGA Medical offers AVEIR DR Leadless Pacemaker, Assurity MRI Pacemaker, Gallant ICD, Assert-IQ ICM, and Merlin.net Patient Care Network.

AGA Medical has 1 investor. Key investors include St. Jude Medical.

AGA Medical operates through Aga Medical Corporation.

Yes. AGA Medical was acquired by St. Jude Medical in October 2010.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available